Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-24 02:21 | 2026-02-23 | RLYB | Rallybio Corp | Lieber Jonathan I | Officer | SELL | $5.06 | 789 | $3,992 | 4,115 |
| 2026-02-24 01:31 | 2026-02-19 | ANIP | Ani Pharmaceuticals Inc. | Davis Krista | Officer | SELL | $77.74 | 3,814 | $296,495 | 49,263 |
| 2026-02-24 01:31 | 2026-02-20 | ANIP | Ani Pharmaceuticals Inc. | Mutz Christopher | Officer | SELL | $78.02 | 5,323 | $415,300 | 84,840 |
| 2026-02-24 01:20 | 2026-02-19 | PTCT | PTC THERAPEUTICS, INC. | Boulding Mark Elliott | Officer | SELL | $69.48 | 3,019 | $209,763 | 105,212 |
| 2026-02-24 01:20 | 2026-02-20 | JNJ | JOHNSON & JOHNSON | Schmid Timothy | Officer | SELL | $245.66 | 1,322 | $324,763 | 25,447 |
| 2026-02-24 00:55 | 2026-02-19 | REGN | REGENERON PHARMACEUTICALS, INC. | Zoghbi Huda Y | Director | OPT+S | $781.33 | 1,638 | $1,279,812 | 1,703 |
| 2026-02-24 00:39 | 2026-02-19 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Sensenig Bethany | Director | OPT+S | $51.01 | 4,475 | $228,265 | 0 |
| 2026-02-24 00:30 | 2026-02-19 | PAHC | PHIBRO ANIMAL HEALTH CORP | BENDHEIM JACK | Director, Officer, 10% owner | SELL | $50.84 | 14,080 | $715,775 | 22,600 |
| 2026-02-23 20:52 | 2026-02-19 | EQ | Equillium, Inc. | Zedelmayer Christine | Officer | OPT+S | $1.76 | 185,937 | $328,104 | 191,444 |
| 2026-02-23 16:31 | 2026-02-19 | PMN | ProMIS Neurosciences Inc. | Kaplan Johanne | Officer | BUY | $15.35 | 1,629 | $25,005 | 3,941 |
| 2026-02-23 15:49 | 2026-02-19 | LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | BUY | $1.47 | 150,000 | $219,750 | 1,804,186 |
| 2026-02-21 00:05 | 2026-02-19 | CTNM | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Officer | OPT+S | $16.00 | 100 | $1,600 | 156,052 |
| 2026-02-21 00:05 | 2026-02-18 | PVLA | PALVELLA THERAPEUTICS, INC. | Goin Kathleen | Officer | OPT+S | $79.40 | 4,302 | $341,564 | 0 |
| 2026-02-21 00:30 | 2026-02-18 | ANNX | Annexon, Inc. | ARTIS DEAN RICHARD | Officer | SELL | $5.10 | 5,290 | $26,979 | 123,487 |
| 2026-02-21 00:30 | 2026-02-18 | ANNX | Annexon, Inc. | Yednock Ted | Officer | SELL | $5.11 | 7,857 | $40,149 | 97,227 |
| 2026-02-21 00:30 | 2026-02-18 | ANNX | Annexon, Inc. | Overdorf Michael | Officer | SELL | $5.10 | 6,225 | $31,748 | 124,464 |
| 2026-02-21 00:26 | 2026-02-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Shah Gaurav | Officer | SELL | $3.34 | 5,990 | $19,995 | 1,046,055 |
| 2026-02-21 00:09 | 2026-02-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Wilson Martin | Officer | SELL | $3.34 | 1,376 | $4,593 | 682,000 |
| 2026-02-21 01:20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Gravier Pierre | Officer | SELL | $69.36 | 2,992 | $207,525 | 87,318 |
| 2026-02-21 01:20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Klein Matthew B. | Director, Officer | SELL | $69.36 | 7,371 | $511,253 | 387,082 |
| 2026-02-21 01:20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Utter Christine Marie | Officer | SELL | $69.36 | 2,494 | $172,984 | 70,199 |
| 2026-02-21 01:20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Golden Lee Scott | Officer | SELL | $69.36 | 2,484 | $172,290 | 89,944 |
| 2026-02-21 01:20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Almstead Neil Gregory | Officer | SELL | $69.36 | 3,121 | $216,473 | 6,726 |
| 2026-02-21 01:20 | 2026-02-18 | PTCT | PTC THERAPEUTICS, INC. | Pauwels Eric | Officer | SELL | $69.36 | 3,019 | $209,398 | 77,122 |
| 2026-02-21 04:23 | 2026-02-12 | TLPH | TALPHERA, INC. | ASADORIAN RAFFI | Officer | BUY | $0.81 | 45,000 | $36,554 | 91,256 |
| 2026-02-21 04:25 | 2026-02-12 | TLPH | TALPHERA, INC. | Dasu Badri N | Officer | BUY | $0.81 | 35,000 | $28,431 | 76,230 |
| 2026-02-21 04:27 | 2026-02-12 | TLPH | TALPHERA, INC. | Aslam Shakil | Officer | BUY | $0.81 | 35,000 | $28,431 | 83,178 |
| 2026-02-21 04:28 | 2026-02-12 | TLPH | TALPHERA, INC. | Angotti Vincent J. | Director, Officer | BUY | $0.81 | 105,364 | $85,587 | 586,954 |
| 2026-02-21 03:10 | 2026-02-18 | NKTR | NEKTAR THERAPEUTICS | ROBIN HOWARD W | Director, Officer | SELL | $73.00 | 423 | $30,879 | 75,489 |
| 2026-02-21 03:10 | 2026-02-18 | NKTR | NEKTAR THERAPEUTICS | Zalevsky Jonathan | Officer | SELL | $73.00 | 180 | $13,140 | 21,174 |
| 2026-02-21 02:25 | 2026-02-18 | MPLT | MapLight Therapeutics, Inc. | Pavlov George | Director | BUY | $17.65 | 25,000 | $441,168 | 25,000 |
| 2026-02-21 01:28 | 2026-02-18 | SEPN | Septerna, Inc. | Bhatt Elizabeth | Officer | OPT+S | $28.97 | 4,000 | $115,860 | 174,209 |
| 2026-02-21 00:41 | 2026-02-18 | PLYX | Polaryx Therapeutics, Inc. | Landis G. Michael | Director, Officer | BUY | $2.79 | 2,867 | $7,991 | 228,225 |
| 2026-02-21 00:30 | 2026-02-18 | ANNX | Annexon, Inc. | Lew Jennifer | Officer | SELL | $5.11 | 7,851 | $40,119 | 113,765 |
| 2026-02-21 00:30 | 2026-02-18 | ANNX | Annexon, Inc. | Dananberg Jamie | Officer | SELL | $5.10 | 5,290 | $26,979 | 73,152 |
| 2026-02-21 00:31 | 2026-02-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | Militello John | Officer | SELL | $3.34 | 1,157 | $3,862 | 91,019 |
| 2026-02-21 00:15 | 2026-02-18 | KROS | Keros Therapeutics, Inc. | Regnante Keith | Officer | SELL | $16.35 | 4,739 | $77,483 | 39,261 |
| 2026-02-21 00:15 | 2026-02-18 | KROS | Keros Therapeutics, Inc. | Cho Esther | Officer | SELL | $16.35 | 4,745 | $77,581 | 39,755 |
| 2026-02-21 00:15 | 2026-02-18 | KROS | Keros Therapeutics, Inc. | Lerner Lorena Raquel | Officer | SELL | $16.35 | 3,873 | $63,324 | 31,127 |
| 2026-02-21 00:15 | 2026-02-19 | KROS | Keros Therapeutics, Inc. | Seehra Jasbir | Director, Officer | SELL | $16.17 | 7,015 | $113,433 | 385,708 |
| 2026-02-21 00:01 | 2026-02-18 | ALXO | Alx Oncology Holdings Inc. | Pinto Shelly | Officer | SELL | $2.27 | 565 | $1,283 | 87,708 |
| 2026-02-20 00:12 | 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | Officer | SELL | $484.31 | 3,619 | $1,752,704 | 8,486 |
| 2026-02-20 00:06 | 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | Officer | SELL | $484.93 | 2,848 | $1,381,090 | 20,727 |
| 2026-02-20 00:03 | 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | Officer | SELL | $484.87 | 2,195 | $1,064,297 | 7,750 |
| 2026-02-20 00:08 | 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | Officer | SELL | $484.18 | 3,720 | $1,801,161 | 15,748 |
| 2026-02-20 00:10 | 2026-02-17 | TVTX | Travere Therapeutics, Inc. | REED ELIZABETH E | Officer | OPT+S | $27.83 | 10,000 | $278,315 | 105,211 |
| 2026-02-20 05:02 | 2026-02-17 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Smith Hunter C | Officer | SELL | $101.31 | 7,954 | $805,813 | 110,512 |
| 2026-02-20 03:44 | 2026-02-18 | KALV | KalVista Pharmaceuticals, Inc. | Yea Christopher | Officer | OPT+S | $15.00 | 1,109 | $16,635 | 224,173 |
| 2026-02-20 03:44 | 2026-02-18 | KALV | KalVista Pharmaceuticals, Inc. | Audhya Paul K. | Officer | OPT+S | $15.00 | 1,163 | $17,445 | 133,087 |
| 2026-02-20 03:45 | 2026-02-18 | KALV | KalVista Pharmaceuticals, Inc. | Palleiko Benjamin L | Director, Officer | OPT+S | $15.00 | 1,038 | $15,570 | 429,667 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.